Metabonomic phenotype of "formula corresponding to pattern types" based on "Qi and Yin deficiency pattern" of myocardial ischemia rat model

Yaoxue Xuebao

Volumn 46, Issue 8, 2011, Pages 976-982

  Yan, Bei ^a,b   A, Ji Ye ^b   Hao, Hai Ping ^b   Wang, Guang Ji ^b   Liu, Lin Sheng ^b   Zha, Wei Bin ^b   Zhang, Ying ^b   Gu, Sheng Hua ^b  

^a BEIJING HOSPITAL   (China)

^b CHINA PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Formula corresponding to pattern types; GC TOF MS; Metabonomics; Myocardial ischemia; Qi and Yin deficiency pattern; Sheng mai injection

Indexed keywords

ENDOTHELIN 1; PROPRANOLOL; SHENG MAI; UNCLASSIFIED DRUG;

AMINO ACID METABOLISM; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARDIOVASCULAR DISEASE; CHINESE MEDICINE; DRUG EFFICACY; DRUG FORMULATION; ENERGY METABOLISM; HEART MUSCLE ISCHEMIA; INJECTION; LIPID METABOLISM; METABOLITE; METABOLOMICS; NONHUMAN; PATTERN RECOGNITION; PHENOTYPE; RAT; SALVIA; SLEEP DISORDER;

ANIMALS; ANTI-ARRHYTHMIA AGENTS; DRUG COMBINATIONS; DRUGS, CHINESE HERBAL; ENDOTHELIN-1; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; INJECTIONS; MALE; MEDICINE, CHINESE TRADITIONAL; METABOLOMICS; MYOCARDIAL ISCHEMIA; PANAX; PLANTS, MEDICINAL; PROPRANOLOL; QI; RATS; RATS, SPRAGUE-DAWLEY; SALVIA; SCHISANDRACEAE; YIN DEFICIENCY;

EID: 80053543440     PISSN: 05134870     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Yuan P, Zhang JP. Discussion on 'combination between disease and syndrome, 'correspondence between recipe and syndrome' through the connotation of 'disease' [J]. J Tradit Chin Med, 2008, 49: 654-655.
2. Dou ZF, Guo L, Zhang JL, et al. Thinking about studies on 'correspondence between recipe and syndrome' [J]. J Tradit Chin Med, 2006, 47: 563-570.
3. Lu Y. Thoughts and methods of research on 'correspondence between recipe and syndrome' by system biology [J]. Pharm Clin Chin Mater Med, 2007, 23: 231-233.
4. Yan B, A JY, Hao HP, et al. Metabonomic phenotype and identification of "heart blood stasis obstruction pattern" and "qi and yin deficiency pattern" myocardial ischemia rat model [J]. Sci China Ser C, 2009, 52: 1081-1090.
5. Cai SH, Liu XN, Chen H. Application of Chinese herbal injection in cardiology department based on 'identifying pattern' [J]. J Fujian Coll Tradit Chin Med, 2007, 17: 19-22.
6. Pinelli A, Trivulzio S, Tomasoni L, et al. Isoproterenol-induced myocardial infarction in rabbits. Protection by propranolol or labetalol: a proposed non-invasive procedure [J]. Eur J Pharm Sci, 2004, 23: 277-285. (Pubitemid 39369883)
7. Blidaru M, Cuparencu B, Pleşca-Manea L. The influence of intracerebroventricular administration of (+/-) propranolol and (+/-) verapamil on experimental myocardial ischemia and necrosis in rats [J]. Acta Physiol Hung, 2000, 87: 99-111.
8. Golomb E, Abassi ZA, Cuda G, et al. Angiotensin II maintains, but does not mediate, isoproterenol-induced cardiac hypertrophy in rats [J]. Am J Physiol, 1994, 267: H1496-H1506.
9. Prodanov K, Kolarova R, Tsakova L, et al. Dynamic biochemical, metrometric and histomorphological studies in isoproterenol-induced myocardial hypertrophy and its regression in rats [J]. Eksp Med Morfol, 1991, 30: 26-30.
10. Monti JM. Disturbances of sleep and wakefulness associated with the use of antihypertensive agents [J]. Life Sci, 1987, 41: 1979-1988. (Pubitemid 18006126)
11. Hilakivi LA, Taira T, Hilakivi I, et al. Early postnatal treatment with propranolol affects development of brain amines and behavior [J]. Psychopharmacology (Berl), 1988, 96: 353-359.
12. Ongini E, Milani S, Marzanatti M, et al. Effects of selected beta-adrenergic blocking agents on sleep stages in spontaneously hypertensive rats [J]. J Pharmacol Exp Ther, 1991, 257: 114-119.
13. 2 production and lipid synthesis by 2-hydroxybutyric acid in rat brain [J]. Braz J Med Biol Res, 2001, 34: 627-631.
14. Anderson ME. Glutathione: an overview of biosynthesis and modulation [J]. Chem Biol Interact, 1998, 111-112: 1-14. (Pubitemid 28271929)
15. Li Yang, Zhang TJ, Liu SX, et al. Advanced research on the constituents and pharmacological activities of ginseng [J]. Chin Tradit Herb Drugs, 2009, 40: 64-66.
16. Zhao CH, Chen XC, Jin JS, et al. Effect of ginsenoside Rg1 on expression of p21, cyclin E and CDK2 in the process of cell senescence [J]. Acta Pharm Sin, 2004, 39: 673-676. (Pubitemid 40081822)
17. Su MW, Wang NP, Xin HW, et al. The progress in the study of pharmacological actions in Schisandra chinensis [J]. China Pharm, 2009, 12: 960-962.
18. Kim H, McGrath BM, Silverstone PH. A review of the possible relevance of inositol and the phosphatidylinositol second messenger system (Pi-cycle) to psychiatric disorders-focus on magnetic resonance spectroscopy (MRS) studies [J]. Hum Psychopharmacol, 2005, 20: 309-326. (Pubitemid 41093934)
19. Yanagisawa M, Kurihara H, Kimura S, et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells [J]. Nature, 1988, 332: 411-415. (Pubitemid 18090241)
20. Rubanyi GM, Polokoff MA. Endothelins: molecular biology, biochemistry, pharmacology, physiology, and pathophysiology [J]. Pharmacol Rev, 1994, 46: 325-415.
21. Simonson MS. Endothelins: multifunctional renal peptides [J]. Physiol Rev, 1993, 73: 375-411.
22. Palma BD, Gabriel A Jr, Bignotto M, et al. Paradoxical sleep deprivation increases plasma endothelin levels [J]. Braz J Med Biol Res, 2002, 35: 75-79. (Pubitemid 34183205)